Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Investigational New Drugs
|
February 4, 2018
The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells
Alexandra Canonici, Zulfiqar Qadir, Neil T Conlon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2024
Distal Immunization and Systemic Cytokines Establish a Transient Immune Alert State in the Intestine
Yixuan Wu, Jessica Y Huang, Michael T Conlon, et al.
The Journal of Infectious Diseases
|
March 1, 1986
Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine
E Telzak, S M Wolff, C A Dinarello, et al.
The AAPS Journal
|
October 13, 2022
FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures
Taylor J Allen-Coyle, Jin Niu, Eva Welsch, et al.
Virus Research
|
March 26, 2025
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states
Mallory L Myers, Michael T Conlon, John R Gallagher, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2024
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states
Mallory L Myers, Michael T Conlon, John R Gallagher, et al.
Investigational New Drugs
|
August 1, 2018
HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer
Alexandra Canonici, Laura Ivers, Neil T Conlon, et al.
Molecular Cancer
|
June 25, 2014
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
Martina Sj McDermott, Brigid C Browne, Neil T Conlon, et al.
Molecular Cancer
|
November 2, 2023
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
Martina S J McDermott, Brigid C Browne, Neil T Conlon, et al.
Science (New York, N.Y.)
|
June 1, 1979
Voyager 1: energetic ions and electrons in the jovian magnetosphere
R E Vogt, W R Cook, A C Cummings, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Investigational New Drugs
|
February 4, 2018
The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells
Alexandra Canonici, Zulfiqar Qadir, Neil T Conlon, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2024
Distal Immunization and Systemic Cytokines Establish a Transient Immune Alert State in the Intestine
Yixuan Wu, Jessica Y Huang, Michael T Conlon, et al.
The Journal of Infectious Diseases
|
March 1, 1986
Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccine
E Telzak, S M Wolff, C A Dinarello, et al.
The AAPS Journal
|
October 13, 2022
FOLFIRINOX Pharmacodynamic Interactions in 2D and 3D Pancreatic Cancer Cell Cultures
Taylor J Allen-Coyle, Jin Niu, Eva Welsch, et al.
Virus Research
|
March 26, 2025
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states
Mallory L Myers, Michael T Conlon, John R Gallagher, et al.
Biorxiv : the Preprint Server for Biology
|
October 7, 2024
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states
Mallory L Myers, Michael T Conlon, John R Gallagher, et al.
Investigational New Drugs
|
August 1, 2018
HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer
Alexandra Canonici, Laura Ivers, Neil T Conlon, et al.
Molecular Cancer
|
June 25, 2014
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
Martina Sj McDermott, Brigid C Browne, Neil T Conlon, et al.
Molecular Cancer
|
November 2, 2023
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
Martina S J McDermott, Brigid C Browne, Neil T Conlon, et al.
Science (New York, N.Y.)
|
June 1, 1979
Voyager 1: energetic ions and electrons in the jovian magnetosphere
R E Vogt, W R Cook, A C Cummings, et al.
Page
of 5